Thymic stromal lymphopoietin signaling in B cells from progenitors to plasma cells
- 7 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 117 (2)
Abstract
Thymic stromal lymphopoietin is an established pleotropic alarmin cytokine that is generated at barrier tissues to induce type 2 immune responses, but its role in regulating the diversity of B cells is poorly understood. Here, we will highlight the key findings that underpin our limited understanding of the role thymic stromal lymphopoietin in modulating different stages of B cell development. We will also provide an overview of how thymic stromal lymphopoietin drives B cell-mediated immune disease and how novel thymic stromal lymphopoietin-blocking biologics could be used to modulate B cell responses. Thymic stromal lymphopoietin is critical for the regulation, diversity, and longevity of humoral immunity.Keywords
Funding Information
- National Institutes of Health (F32AI154787, R21AI169418)
This publication has 75 references indexed in Scilit:
- Tezepelumab: First ApprovalDrugs, 2022
- IgA glycosylation and immune complex formation in IgANSeminars in Immunopathology, 2021
- Clonal B cells of HCV‐associated mixed cryoglobulinemia patients contain exhausted marginal zone‐like and CD21low cells overexpressing Stra13European Journal of Immunology, 2012
- Glycosylation of IgA1 and pathogenesis of IgA nephropathySeminars in Immunopathology, 2012
- TSLPR gene polymorphism is associated with systemic lupus erythematosus in the Korean populationGenes & Genomics, 2012
- Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV‐1 gp140 vaccination in miceEuropean Journal of Immunology, 2011
- TSLP enhances the function of helper type 2 cellsEuropean Journal of Immunology, 2011
- Characterization of thymic stromal‐derived lymphopoietin (TSLP) in murine B cell development in vitroEuropean Journal of Immunology, 1996
- Positive and negative selection events during B lymphopoiesisCurrent Opinion in Immunology, 1995
- Long‐term proliferating early pre B cell lines and clones with the potential to develop to surface Ig‐positive, mitogen reactive B cells in vitro and in vivo.The EMBO Journal, 1991